It is well known that gemfibrozil increases the biliary output of cholester
ol and phospholipids, but we have little knowledge about the impact these c
hanges have on liver cholesterol and phospholipid biosynthetic pathways. In
the present study, no changes were detected in liver lipids and CTP:phosph
ocholine cytidylyltransferase after gemfibrozil administration to rats. On
the contrary, 3-hydroxy-3-methylglutaryl-CoA reductase mRNA (9.9-fold) and
Rd activity (16.7-fold) and phosphatidate phosphohydrolase activity (1.7-fo
ld) increased, while plasma apo B-cholesterol (40%) and triglyceride (43%)
levels decreased. As a part of a compensatory homeostatic response, we repo
rt for the first time that gemfibrozil administration to rats increased the
hepatic sterol regulatory element binding protein-2 (SREBP-2) mRNA (2.9-fo
ld) and mature protein (2.2-fold) levels. An early increase in the transcri
ptional activity of SREBP-2 elicited by gemfibrozil administration might be
responsible for the observed changes in HMG-CoA reductase, phosphatidate p
hosphohydrolase, and SREBP-2 expression. (C) 2001 Elsevier Science Inc. All
rights reserved.